Here are eight observations:
1. The report revealed the increasing focus on minimizing load to avoid adverse reactions is a market trend.
2. Interbody cages will likely dominate the market through 2027.
3. Interbody fusion will lead the market in the procedure segment.
4. Hospitals represent the dominant end user of spinal fusions, but the ambulatory surgery center segment will see a 6.6 percent CAGR through 2027.
5. North America will capture the greatest market share by the end of 2017.
6. By the end of 2017, the combined market shares of North America, Western Europe and the Asia-Pacific region will account for 68.6 percent of the market.
7. The Asia-Pacific region, excluding Japan, will see an 8.9 percent CAGR through 2027.
8. Key market players include: Zimmer Biomet, K2M, MicroPort Scientific, Medtronic, DePuy Synthes, Stryker, Integra Lifesciences, Orthofix, Shandong Weigao Group Medical Polymer, Bonovo Orthopedics, Suzhou Gemmed Medical Instrument, NuVasive, B. Braun Melsungen, Globus Medical, RTI Surgical, Expanding Orthopedics, Vallum, ChoiceSpine, Life Spine and Precision Spine.
More articles on devices:
Global large joint reconstruction market to expand at 6.1% CAGR — 3 points
Global artificial lumbar disc market to see 21.2% CAGR through 2023
Johnson & Johnson breaks ground on $180M China device plant, to open in 2019: 5 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.